Sydney, Thursday, 1 December 2011
Sydney, Thursday, 1 December 2011: Cellmid Limited (ASX: CDY) completed its diagnostic study in Kumamoto, Japan, measuring the blood midkine levels of 233 healthy volunteers. The results confirmed findings from previous research; 95% of the individuals tested had midkine levels below 500 picogram/mL, whilst 90% were below 350 picogram/mL.
Click here to read more »